India’s medicine management company has revealed that samples of Johnson & Johnson’s (J&J) baby shampoo taken from two batches had failed the quality check as they contained “harmful ingredients.”
The watchdog’s findings come just some months after Indian authorities launched an investigation into the corporate’s baby powder to see if it incorporates cancer-causing asbestos. Samples of J&J’s baby shampoo and cleaning soap merchandise have been additionally collected as a matter of routine.
The American pharmaceutical firm rejected the findings. J&J acknowledged that the outcomes it acquired from the regulator indicated that formaldehyde had been found within the samples. Formaldehyde is thought as a carcinogen (a substance able to inflicting most cancers) and is used to make constructing supplies. Research research have established a hyperlink between formaldehyde and the next danger of leukemia.
“We do not accept the interim results given to us, which mentioned samples to ‘contain harmful ingredients – identification positive for formaldehyde,’” a J&J spokeswoman advised Reuters.
We unequivocally keep that our merchandise are secure and our assurance course of is amongst probably the most rigorous on the earth,” she added. The firm has contested the interim check outcomes of the federal government evaluation that had been based mostly on “unknown and unspecified methods,” in keeping with the spokesperson.
The two batches of the examined baby shampoo had been manufactured at J&J’s plant within the northern state of Himachal Pradesh and are on account of expire in September 2021. Rajasthan has reportedly ordered the withdrawal of the contaminated batches and requested the regulators in different states to comply with swimsuit.
“We have confirmed to the Indian authorities that we do not add formaldehyde as an ingredient in our shampoo nor does Johnson’s baby shampoo include any ingredient that may launch formaldehyde over time,” mentioned J&J.
Inspections at J&J Indian services adopted a Reuters’ report that the agency knew for many years that cancer-causing asbestos may very well be present in its product. The US firm has described the report as “one-sided, false and inflammatory.”
